2,066
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Inhibition of mammalian carbonic anhydrase isoforms I, II and VI with thiamine and thiamine-like molecules

, &
Pages 316-319 | Received 28 Sep 2011, Accepted 28 Oct 2011, Published online: 06 Dec 2011

References

  • Parui R, Gambhir KK, Mehrotra PP. Changes in carbonic anhydrase may be the initial step of altered metabolism in hypertension. Biochem Int 1991;23:779–789.
  • Tashian RE, Hewett-Emmet D, Venta PJ. Diversity and evolution in the carbonic anhydrase gene family. In: Botrè F, Gros G, Storey BT, eds. Carbonic anhydrase: From biochemistry and genetics to physiology and clinical medicine. Weinheim: VCH Verlagsgesellschaft; 1991, 151–161.
  • Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336–4350.
  • Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–181.
  • Bayram E, Senturk M, Kufrevioglu OI, Supuran CT. In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. Bioorg Med Chem 2008;16:9101–9105.
  • Ekinci D, Ceyhun SB, Sentürk M, Erdem D, Küfrevioglu OI, Supuran CT. Characterization and anions inhibition studies of an a-carbonic anhydrase from the teleost fish Dicentrarchus labrax. Bioorg Med Chem 2011;19:744–748.
  • Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995;64:375–401.
  • Winum JY, Rami M, Scozzafava A, Montero JL, Supuran C. Carbonic anhydrase IX: A new druggable target for the design of antitumor agents. Med Res Rev 2008;28:445–463.
  • Güzel O, Innocenti A, Scozzafava A, Salman A, Parkkila S, Hilvo M et al. Carbonic anhydrase inhibitors: Synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides. Bioorg Med Chem 2008;16:9113–9120.
  • Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A et al. Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates. Bioorg Med Chem 2007;15:2298–2311.
  • Rami M, Innocenti A, Montero JL, Scozzafava A, Winum JY, Supuran CT. Synthesis of rhodamine B-benzenesulfonamide conjugates and their inhibitory activity against human a- and bacterial/fungal β-carbonic anhydrases. Bioorg Med Chem Lett 2011;21:5210–5213.
  • Rami M, Maresca A, Smaine FZ, Montero JL, Scozzafava A, Winum JY et al. Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII. Bioorg Med Chem Lett 2011;21:2975–2979.
  • Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A et al. Targeting Tumor Hypoxia: Suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 2011;71:3364–3376.
  • Ekinci D, Cavdar H, Talaz O, Sentürk M, Supuran CT. NO-releasing esters show carbonic anhydrase inhibitory action against human isoforms I and II. Bioorg Med Chem 2010;18:3559–3563.
  • Senturk M, Gulcin I, Dastan A, Kufrevioglu OI, Supuran CT. Carbonic anhydrase inhibitors: Inhibitor of human erythrocyte I and II isoenzymes with antioxidant phenolic compounds. Bioorg Med Chem 2009;17:3207–3211.
  • Sentürk M, Gülçin I, Beydemir S, Küfrevioglu OI, Supuran CT. In Vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Chem Biol Drug Des 2011;77:494–499.
  • Durdagi S, Sentürk M, Ekinci D, Balaydin HT, Göksu S, Küfrevioglu ÖI,et al. Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site. Bioorg Med Chem 2011;19:1381–1389.
  • Valverde LF, Cedillo FD, Reyes GC, Ramos ML. Synthesis and antibacterial activity of pregnenolone-vitamin B1 conjugate. J Mex Chem Soc 2008;52:130–135.
  • Ozturk Sarikaya SB, Topal F, Senturk M, Gulcin I, Supuran CT. In vitro inhibition of some phenolic compounds on some α-carbonic anhydrase isozymes. Bioorg Med Chem Lett 2011;21:4259–4262.
  • Kivela J, Parkkila S, Waheed A, Parkkila AK, Sly WS, Rajaniemi H. Secretory carbonic anhydrase isoenzyme (VI) in human serum, Clin Chem 1997;43:2318–2322.
  • Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. J Biol Chem 1971;246:2561–2573.
  • Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973;22:3099–3108.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
  • Laemmli DK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
  • Renzi G, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties. Bioorg Med Chem Lett 2000;10:673–676.
  • Nair SK, Ludwig PA, Christianson DW. Two-site binding of phenol in the active site of human carbonic anhydrase II: Structural implications for substrate association. J Am Chem Soc 1994;116:3659–3660.
  • Ekinci D, Beydemir S, Alim Z. Some drugs inhibit in vitro hydratase and esterase activities of human carbonic anhydrase-I and II. Pharmacol Rep 2007;59:580–587.
  • Supuran CT, Mincione F, Scozzafava A, Briganti F, Mincione G, Ilies MA. Carbonic anhydrase inhibitors. Part 52. Metal complexes of heterocyclic sulfonamides: A new class of strong topical intraocular pressure lowering agents with potential use as antiglaucoma drugs. Eur J Med Chem 1998;33:247–254.
  • Innocenti A, Maresca A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: Thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors? Bioorg Med Chem Lett 2008;18:3938–3941.
  • Senturk M, Ekinci D, Goksu S, Supuran CT. Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI. J Enzym Inhib Med Ch 2011. DOI: 10.3109/14756366.2011.591290.
  • Alp C, Ekinci D, Gültekin MS, Sentürk M, Sahin E, Küfrevioglu OI. A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis of carbonic anhydrase inhibitory potencies. Bioorg Med Chem 2010;18:4468–4474.
  • Balaydin HT, Durdagi S, Ekinci D, Senturk M, Goksu S, Menzek A. Inhibition of human carbonic anhydrase isozymes I, II and VI with a series of bisphenol, methoxy and bromophenol compounds. J Enzym Inhib Med Ch 2011. DOI:10.3109/14756366.2011.596836.
  • Balaydin HT, Soyut H, Ekinci D, Goksu S, Beydemir S, Menzek A, Sahin E. Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols including natural products. J Enzym Inhib Med Ch 2011. DOI: 10.3109/14756366.2011.574131.
  • Ceyhun SB, Sentürk M, Yerlikaya E, Erdogan O, Küfrevioglu OI, Ekinci D. Purification and characterization of carbonic anhydrase from the teleost fish Dicentrarchus labrax (European seabass) liver and toxicological effects of metals on enzyme activity. Environ Toxicol Pharmacol 2011;32:69–74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.